Font Size: a A A

Analysis Of Pfizer Inc. Core Competitiveness Of Ningxia Kai Yuan Pharmaceutical Company’s Advice

Posted on:2015-02-11Degree:MasterType:Thesis
Country:ChinaCandidate:X GongFull Text:PDF
GTID:2269330428962464Subject:Business administration
Abstract/Summary:PDF Full Text Request
Pfizer Inc., which was founded in1849has seen160years of development and headquartered in New York, the United States becomes the world’s largest biopharmaceutical company based on research and development. Pfizer Inc. employed innovative scientific technologies and global resources to improve the health in every stage of mankind. At present, its products cover chemicals, biologicals, and vaccines and healthy drugs and so on, which are wide and promising medical and health sectors. Meanwhile, its outstanding research and development and production capacity wins leadership in the world. Pfizer Inc. has been committed to pursuing strict quality, safety and value standards in the discovery, development and production of human medicines. Therefore, it has kept the leading position in the market of pharmaceutical industry.This paper summarizes the experience in building core competitiveness of Pfizer Inc. through a study of its core competitiveness. By a comparison of core competiveness of Pfizer Inc. and Ningxia Qiyuan Pharmaceutical Co., Ltd., the paper provides some suggestions on the enhancement of core competiveness for Ningxia Qiyuan Pharmaceutical Co., Ltd. and thus presents the practical referential experience for the development of Ningxia Qiyuan Pharmaceutical Co., Ltd..
Keywords/Search Tags:The core competitiveness, Comparative analysis, Suggestions
PDF Full Text Request
Related items